| http://www.w3.org/ns/prov#value | - Regulatory action is developing within the EU and the USA, aligning research (www.cost-dare.eu) and regulatory instruments, while research from the UK demonstrated that the current exposure-based trigger value for veterinary medicines fails to protect against AMR. Indeed, very low concentrations of antibiotics should be evaluated against criteria such as selection, changing community structures an
|
